Joaquim Trias

Essential Therapeutics, Inc. manufactures pharmaceutical goods for viral and fungal infections

Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA.

Tetraphase Pharmaceuticals, Inc. is engaged in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also develops eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Waltham, MA.

Genmedica Therapeutics SL engages in the research and development of new treatments for diabetes. Its has developed novel NCE-generating platform to generate dual action, small molecules that act against oxidative stress and inflammation, two specific pathways known to be critical in the root causes of the disease. The company was founded by Alec Humayun Mian and Luc Marti Clauzel on June 21, 2004 and is headquartered in Barcelona, Spain.

iMiCROQ SL develops pathogen detection systems for the food safety industry. Its diagnostic systems test for the presence of listeria, staphylococcus, salmonella, and airborne contaminants. The company was founded by Carlos Arias, Viviana Duarte, Diego Bejarano, Pablo Lozano, and Ioanis Katakis on April 23, 2010, and is headquartered in Tarragona, Spain.

Adan Medical Innovation SL is a Spanish company that aims to increase education and awareness about anaphylaxis and its treatment to prevent fatal outcomes. Adan Medical Innovation is based in Bilbao, ES. The company has developed Allergobox, a smart medical device connected to a telecontrol platform that helps manage autoinjectors of adrenaline to treat anaphylaxis in public spaces. The concept of Alergoprotección was created to protect public spaces against fatal outcomes of severe allergic reactions and to raise awareness about anaphylaxis. The company's mission is to improve the quality of life of patients who suffer from severe allergic reactions. The company was founded in 2013 by Adrian Curran, Anna Sala. Xavier Guillem has been the CEO of the company since 2015.

Arixa Pharmaceuticals, Inc. engages in the development of oral antibiotics for resistant gram-negative infections. The company was founded by Eric Gordon, John Gordon Freund, and Joaquim Trias in 2016 and is headquartered in Palo Alto, CA.

BCN Health Venture Partners SL is into identifying research projects that are contributing solutions to global health challenges. The company was founded by Marta Príncep, Joan Bigorra, Joaquim Trias, and is headquartered in Albert G. Zamora and is headquartered in Barcelona, Spain.